世界の薬事規制動向＆情報を配信

China-US Relationship Hinges On Changing Internal, External Forces

By Brian Yang 16 Jun 2022

Given the ongoing election challenges in the US, China has yet to officially congratulate Joe Biden as the next US president, although many world leaders are already hailing a reset in US foreign policy. Many are wondering if this and other moves indicate a quiet internal shift for China's high tech and life sciences sectors, just days after Beijing concluded a high-level plenary meeting outlining its priorities for the next five years.

Topic US Election 2020 China

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Scrip Asia 100 Report Extract

26 Mar 2021

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Health Sector On High Alert As Wuhan Coronavirus Spreads

By Brian Yang 27 Nov 2020

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”

Topic China Infectious Diseases Policy & Regulation Coronavirus

Medtech Insight: 世界の医療機器・医療技術の最新情報

Diagnostics Sector On High Alert As Wuhan Coronavirus Spreads

By Brian Yang 27 Nov 2020

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, diagnostics companies are rushing to have test kits ready.

Topic China In Vitro Diagnostics Coronavirus

世界の薬事規制動向＆情報を配信

China Regulatory Express Former CFDA Commissioner Bi Makes Comeback

By Brian Yang 27 Nov 2020

Ex-China FDA Commissioner Bi Jingquan’s new role, a waiver of bioequivalence testing for hundreds of drugs, data accuracy requirements and a new crackdown on compliance issues.

Topic China Regulation Compliance

世界の薬事規制動向＆情報を配信

China Coronavirus Outbreak Response Critical As First US Case Confirmed

By Brian Yang 27 Nov 2020

A quickly spreading coronavirus outbreak in China could upend the country’s healthcare priorities as the health regulators and reimbursement agency officials gear up to “control and prevent” the worst public health emergency since the deadly SARS outbreak in 2003.

Topic China Coronavirus Infectious Diseases Policy & Regulation